Factors Affecting Chronik Kidney Disease Costs : Systematic Review
|
|
Author:
|
ENDANG SUNARIYANTI, TRI MURTI ANDAYANI, DWI ENDARTI, DIAH AYU PUSPANDARI
|
Abstract:
|
Chronic Kidney Disease (CKD) is a disease with a high prevalence and mortality rate. The long treatment process
and the high cost of treatment are things that need attention. Several studies reveal the factors of concomitant
diseases, old age and the high cost of drugs consumed by patients to be one of the factors increasing the cost of
treatment of Chronic Kidney Disease (CKD) in Hospitals. The purpose of this study is to carry out a systematic
review of the factors that influence the cost of treatment in Chronic Kidney Disease (CKD). Researchers
searched for articles within one month (January-February 2020). Searching articles through Pubmed and Google
Scholar uses keywords: Cost of Illness, Cost Analysis, Chronic Kidney Failure, and Influence Factors. Researchers
use PRISMA Diagrams (Preferred reporting items for systematic reviews) to help the selection of articles that
fit the inclusion and exclusion criteria. Articles of original research type in English or Indonesian, full text and
published within the last 10 years (2010-2020) are inclusion criteria. The results of our systematic review of 85
articles were obtained with 29 articles fulfilling the inclusion criteria while the rest were exclusion criteria. Our
results reveal that comorbidities and the severity of Chronic Kidney Disease are factors that influence the cost
of CKD treatment. The more comorbid patients have, the cost of treatment also increases. Neither is the
severity of the disease. Our findings assess that patients with higher severity require greater treatment costs
than patients with mild severity. Hemodialysis (HD) and peritonial dialysis (HD) also contribute to the patient's
significant costs.
|
Keyword:
|
Cost of Illness, Cost Analysis, Chronic Kidney Disease, Factor Affecting
|
EOI:
|
-
|
DOI:
|
https://doi.org/10.31838/ijpr/2021.13.01.644
|
Download:
|
Request For Article
|
|
|